Citation: Expert Review of Endocrinology & Metabolism. 10(4):381-398, 2015 Jul..Journal: Expert review of endocrinology & metabolism.Published: ; 2015ISSN: 1744-6651.Full author list: Aroda VR; Getaneh A.UI/PMID: 30293496.Subject(s): IN PROCESS -- NOT YET INDEXEDInstitution(s): MedStar Health Research InstituteActivity type: Journal Article.Medline article type(s): Journal ArticleDigital Object Identifier: https://dx.doi.org/10.1586/17446651.2015.1054280 (Click here)Abbreviated citation: Expert Rev Endocrinol Metab. 10(4):381-398, 2015 Jul.Abstract: Advances made in diabetes management are not sufficient to reduce morbidity, mortality and cost without making prevention efforts at various levels imperative for substantial impact. Research has demonstrated the efficacy of lifestyle intervention and medications in preventing type 2 diabetes among diverse high-risk groups commonly identified with oral glucose tolerance testing. Efficacy, sustainability and safety data are most comprehensive for lifestyle and metformin, with other medications also demonstrating efficacy and potential in the pharmacoprevention of diabetes. Subsequent implementation studies have demonstrated feasibility of lifestyle intervention programs at health centers, communities, and at local and national government levels. Challenges remain in widespread translation and reaching and engaging at-risk individuals and populations.